Skip to main content
Erschienen in: Drugs 16/2005

01.11.2005 | Adis Drug Profile

Low-Dose Ethinylestradiol/Levonorgestrel

A Viewpoint by Luis Bahamondes

verfasst von: Luis Bahamondes

Erschienen in: Drugs | Ausgabe 16/2005

Einloggen, um Zugang zu erhalten

Excerpt

Almost 45 years have elapsed since the introduction of the first combined oral contraceptive (COC; ‘the pill’) in the market, with millions of women having benefited from its contraceptive and non-contraceptive benefits. Among the most important non-contraceptive benefits are the reduction of anaemia, ovarian cysts, dysmenorrhoea, and endometrial and ovarian cancer. The composition of COC has changed over time, with the introduction of different and new progestogens and with the reduction of estrogen levels. Nevertheless, although new formulations have been introduced, the most common combination used in a COC remains ethinylestradiol plus levonorgestrel. …
Metadaten
Titel
Low-Dose Ethinylestradiol/Levonorgestrel
A Viewpoint by Luis Bahamondes
verfasst von
Luis Bahamondes
Publikationsdatum
01.11.2005
Verlag
Springer International Publishing
Erschienen in
Drugs / Ausgabe 16/2005
Print ISSN: 0012-6667
Elektronische ISSN: 1179-1950
DOI
https://doi.org/10.2165/00003495-200565160-00008

Weitere Artikel der Ausgabe 16/2005

Drugs 16/2005 Zur Ausgabe

Adis Drug Evaluation

Gemtuzumab Ozogamicin

Adis Drug Evaluation

Eprosartan

Adis Drug Evaluation

Escitalopram